首页> 外国专利> EXTENDED RELEASE GASTRORETENTIVE FORMULATION AGAINST HELICOBACTER PYLORI

EXTENDED RELEASE GASTRORETENTIVE FORMULATION AGAINST HELICOBACTER PYLORI

机译:对幽门螺杆菌的延长释放胃内引入配方

摘要

The present document describes extended release gastro retentive dosage form comprising a carboxylated polysaccharide and cinnamaldehyde conjugate formed via an acetal, hemiacetal or cyclic hemiacetal formed between an aldehyde group of the cinnamaldehyde and a hydroxyl group of the carboxylated polysaccharide. The document also describes extended release gastro retentive dosage form comprising an artesunate emulsion having a pH value of from about 7.5 to 7.9 and comprising an artesunate or pharmaceutically acceptable salts thereof, and stereoisomers thereof stabilized with an emulsifying agent. The document also describes the use of the dosage forms for treatment of H. Pylori infection.
机译:本文件描述了延长释放胃保留剂型,其包含通过在肉桂醛的醛基和羧化多糖的醛基之间形成的缩醛,半缩醛或环状半缩醛形成的羧化多糖和肉桂醛缀合物。 该文件还描述了延长的释放胃保留剂型,其包含野生素酸盐的乳液,其具有约7.5至7.9的pH值,并包含野石或其药学上可接受的盐,并用乳化剂稳定立体异构体。 该文件还描述了使用剂型用于治疗 H. pylori 感染。

著录项

  • 公开/公告号WO2020257936A8

    专利类型

  • 公开/公告日2021-08-12

    原文格式PDF

  • 申请/专利权人 SOLSTAR PHARMA;

    申请/专利号WO2020CA50885

  • 申请日2020-06-26

  • 分类号A61K47/36;A61K31/357;A61K47/20;A61K47/28;A61K9;A61K9/107;A61P1;A61P31/04;A61P35;C07D493/18;

  • 国家 CA

  • 入库时间 2022-08-24 20:36:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号